Home/Filings/4/0001387131-16-005871
4//SEC Filing

Ohr Pharmaceutical Inc 4

Accession 0001387131-16-005871

CIK 0001173281operating

Filed

Jun 20, 8:00 PM ET

Accepted

Jun 21, 12:41 PM ET

Size

10.7 KB

Accession

0001387131-16-005871

Insider Transaction Report

Form 4
Period: 2016-06-20
Backenroth Samuel
CEO & VP of Bus. Development
Transactions
  • Purchase

    Common Stock, par value $0.0001 per share

    2016-06-20$2.89/sh+10$29138,709 total
  • Purchase

    Common Stock, par value $0.0001 per share

    2016-06-20$2.88/sh+8$23138,717 total
  • Purchase

    Common Stock, par value $0.0001 per share

    2016-06-20$2.71/sh+200$542141,167 total
  • Purchase

    Common Stock, par value $0.0001 per share

    2016-06-20$2.87/sh+450$1,292139,167 total
  • Purchase

    Common Stock, par value $0.0001 per share

    2016-06-20$2.84/sh+1,800$5,112140,967 total

Issuer

Ohr Pharmaceutical Inc

CIK 0001173281

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001173281

Filing Metadata

Form type
4
Filed
Jun 20, 8:00 PM ET
Accepted
Jun 21, 12:41 PM ET
Size
10.7 KB